TGFB1 and Hepatic fibrosis: Thus, a combination therapy approach that targets TGF-β, its regulating pathways and the associated inflammatory state may represent an option for liver fibrosis treatment (Ebrahimkhani et al., 2011; Bai et al., 2013; Feng et al., 2013; Geng et al., 2020).